• Does This Drug Represent “A Paradigm Shift for Small Molecule Drug Development?”

  • Sep 4 2024
  • Length: 28 mins
  • Podcast

Does This Drug Represent “A Paradigm Shift for Small Molecule Drug Development?”

Listen for free

View show details

  • Summary

  • NAMPT is a critical enzyme that regulates how cells use energy. It can also play an important role in the ability of cancer cells to survive, grow, and spread. While it’s been recognized as a potential target to treat certain cancers, developing NAMPT inhibitors have been challenging because they can disrupt energy metabolism in healthy cells. Remedy Plan Therapeutics believes it’s overcome the challenges of NAMPT inhibition by a unique mechanism of action that can avoid the problem of toxicity. We spoke to Greg Crimmins, founder and CEO of Remedy Plan Therapeutics, about the role of NAMPT in cancer, the challenges of developing NAMPT inhibitors without toxicity, and why he believes the company has solved the problem.
    Show More Show Less
Economics Biological Sciences
Show More Show Less
activate_samplebutton_t1

What listeners say about Does This Drug Represent “A Paradigm Shift for Small Molecule Drug Development?”

Average Customer Ratings

Reviews - Please select the tabs below to change the source of reviews.

Audible.com.au reviews

Amazon Reviews
No Reviews are Available
In the spirit of reconciliation, Audible acknowledges the Traditional Custodians of country throughout Australia and their connections to land, sea and community. We pay our respect to their elders past and present and extend that respect to all Aboriginal and Torres Strait Islander peoples today.